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INTRODUCTION 
 "Only the man who is familiar with the art and science of the past is 
competent to aid in its progress in the future."(17) So wrote Theodor Billroth 
of Vienna, one of the founders of modern surgery in the second half of the 
nineteenth century and a major contributor to the surgery of the thyroid. 
 
 The thyroid gland lies in front  of the neck and gives rise to goiters, 
which are often large and unsightly, sometimes obstruct the trachea and 
esophagus, and may threaten life. For these reasons surgeons have long 
attempted to provide relief, and operations on the thyroid gland have 
evolved through the centuries as part and parcel of surgery as a whole. Until 
about 100 years ago operations were undertaken with trepidation under 
primitive conditions and often themselves proved fatal. Today they are 
routine, safe procedures with little morbidity. 
 
 Goiters (deriverd from latin word ‘guttur’ = throat) are very common 
in many parts of the world and were recognized long before the thyroid 
itself. Thomas Wharton of London described the gland in his Adenographia 
in 1656 (p. E.2), named it "glandul thyroidoeis," and found that one 
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specimen weighed six drachms (26 grams). The first credible accounts of 
thyroid surgery emanated from  the writings of Roger Frugardi published at 
about 1170.(8) The first well-documented partial thyroidectomy was 
undertaken in 1791by Pierre- Joseph Desault(9). Guillaume Dupuytren, also 
of Paris, undertook total thyroidectomy in 1808, there was little blood loss, 
but the patient died from "shock".Dr. Cabaret of St. Malo, who probably 
performed the first successful total thyroidectomy for a midline goiter, the 
size of an ostrich egg, with little bleeding.(10)  The most notable thyroid 
surgeons were Emil Theodor Kocher (1841–1917) and C.A. Theodor 
Billroth (1829–1894), who performed thousands of operations with 
increasingly successful results. In 1909, Kocher was awarded the Nobel 
Prize for medicine in recognition "for his works on the physiology, 
pathology, and surgery of the thyroid gland."(4)Billroth reported 48 
thyroidectomies performed since 1877, in which only four patients died,was 
the first to use artery forceps to prevent and stop hemorrhage. Postoperative 
tetany was probably first described by Wolfler in 1879 in the first of 
Billroth's patients to survive total extirpation .(9) One of Billroth's forty-eight 
patients reported in 1881 died from Hypocalcemic tetany. 
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 The surgical anatomy and blood supply of the parathyroids were 
studied and described by Halsted in 1907(11). Hypocalcemia was presumed to 
be due to inadvertent removal of parathyroid tissue at operation.(12) 
Hypoparathyroidism could not be accounted for entirely by inadvertent 
removal of parathyroid tissue, and it was proposed that damage to the 
vascular pedicle of the gland was a common cause.(13) Another suggestion 
was that in thyrotoxic patients postoperative hypocalcemia was due to the 
hunger of osteoporotic bones for calcium,so called ‘Hungry bone 
syndrome’.(14) 
 
 Despite the advances that have been made in thyroid surgery with the 
use of latest equipment and techniques the danger of hypocalcemic tetany  is 
still real and every surgeon should be thorough about the anatomy of  
thyroid and parathyroid and be ready to deal with its complications . This 
dire complication represents a major concern for thyroid surgeons as the 
consequences of chronic hypocalcaemia are often insidious and potentially 
severe. Permanent hypocalcaemia is a common cause of malpractice 
litigation after endocrine surgery. 
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                AIMS & OBJECTIVES OF THE STUDY 
 
 This study  aims to evaluate the incidence of hypocalcemia(both 
transient and permanent) following near-total thyroidectomy and total 
thyroidectomy. 
This study will include the following; 
1. Incidence of hypocalcemia following Total and Near-Total 
thyroidectomy 
2. Follow up of  patients upto a period of  6 months. 
3. Broad overview of literature about the merits and demerits of  surgical 
procedures used ,early detection and prediction of post-operative 
hypocalcemia ,treatment of hypocalcemia and  measures to prevent its 
occurrence. 
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ANATOMY OF THYROID & PARATHYROID 
GLANDS 
 
THYROID 
 The great Italian Renaissance anatomist, Andreas Vesalius of Padua, 
gave the first description of thyroid  in De Humani Corporis Fabrica in 
1543.1The thyroid gland is the biggest gland in the neck(1). The term thyroid 
gland (Greek thyreoeides, shield-shaped) is, however, attributed to Thomas 
Wharton in his Adenographia (1656), He believed that it served to lubricate, 
drain, and warm the larynx.  In 1776, the thyroid was classified as a ductless 
gland by Albrecht von Haller and was thought to have numerous functions 
ranging from lubrication of the larynx to acting as a reservoir for blood to 
provide continuous flow to the brain, to beautifying women's necks. Burnt 
seaweed was considered to be the most effective treatment for goiters by the 
Chinese from 1600 B.C.(4) In 1776, the thyroid was classified as a ductless 
gland by Albrecht von Haller and was thought to have numerous functions 
ranging from lubrication of the larynx to acting as a reservoir for blood to 
provide continuous flow to the brain, to beautifying women's necks. 
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EMBRYOLOGY 
 
 The thyroid gland arises as an outpouching of the primitive foregut 
around the third week of gestation. It originates at the base of the tongue at the 
foramen cecum. Endoderm cells in the floor of the pharyngeal anlage thicken 
to form the medial thyroid anlage  that descends in the neck anterior to 
structures that form the hyoid bone and larynx. During its descent, the anlage 
remains connected to the foramen cecum via an epithelial-lined tube known as 
the thyroglossal duct. The epithelial cells making up the anlage give rise to the 
thyroid follicular cells. The paired lateral anlages originate from the fourth 
branchial pouch and fuse with the median anlage at approximately the fifth 
week of gestation. The lateral anlages are neuroectodermal in origin 
(ultimobranchial bodies) and provide the calcitonin producing parafollicular or 
C cells, which thus come to lie in the superoposterior region of  the gland. 
Thyroid follicles are initially apparent by 8 weeks, and colloid formation 
begins by the eleventh week of gestation. 
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General Topography 
 The thyroid gland consists typically of two lobes, a connecting 
isthmus, and an ascending pyramidal lobe. One lobe, usually the right, may 
be smaller than the other (7 percent) or may even be completely absent (1.7 
percent). The isthmus is absent in about 10 percent of thyroid glands, and the 
pyramidal lobe is absent in about 50 percent. 
 
 The thyroid gland rests on the anterolateral aspect of the cricothyroid 
and trachea. The gland itself has a bilobed shape and typically weighs 15–25 
g, depending on sex and age. The thyroid lobes extend to the midthyroid 
cartilage superiorly and lie adjacent to the carotid sheaths and 
sternocleidomastoid muscles laterally. The strap muscles (sternohyoid, 
sternothyroid, and superior belly of the omohyoid) are located anteriorly and 
are innervated by the ansa cervicalis (ansa hypoglossi). The thyroid gland is 
enveloped by a loosely connecting fascia that is formed from the partition of 
the deep cervical fascia into anterior and posterior divisions. The true capsule 
of the thyroid is a thin, densely adherent fibrous layer that sends out septa 
that invaginate into the gland, forming pseudolobules. The thyroid capsule is 
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condensed into the posterior suspensory or Berry's ligament near the cricoid 
cartilage and upper tracheal rings. 
Vascular Supply 
 The thyroid gland competes with the adrenal glands for having the 
greatest blood supply per gram of tissue.(15) The thyroid is a highly vascular 
gland that has a redundant arterial supply from the superior thyroid artery (a 
branch of the external carotid artery) and the inferior thyroid artery (ITA) (a 
branch of the thyrocervial trunk) with abundant collaterals.(2) 
Arteries 
 Two paired arteries, the superior and inferior thyroid arteries, and an 
inconstant midline vessel, the thyroid ima artery, supply the thyroid . The 
superior thyroid artery arises from the external carotid artery just above, at, 
or just below the bifurcation of the common carotid artery. It passes 
downward and anteriorly to reach the superior pole of the thyroid gland. In 
part of its course, the artery parallels the external branch of the superior 
laryngeal nerve which supplies the cricothyroid muscle and the 
cricopharyngeus muscle, the lowest voluntary part of the pharyngeal 
musculature. There are six branches of the superior thyroid artery : the 
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infrahyoid, sternocleidomastoid, superior laryngeal, cricothyroid, inferior 
pharyngeal constrictor, and terminal branches of the artery for the blood 
supply of the thyroid and parathyroid glands. Usually there are two branches 
to the thyroid —the anterior and posterior— but occasionally there may be a 
third, the so-called lateral branch. At the superior pole, the superior thyroid 
artery divides into anterior and posterior branches. The anterior branch 
anastomoses with the contralateral artery;108 the posterior branch 
anastomoses with branches of the inferior thyroid artery. From the posterior 
branch, a small parathyroid artery passes to the superior parathyroid gland. 
 The inferior thyroid artery usually arises from the thyrocervical trunk, 
but in about 15 percent of individuals it arises directly from the subclavian 
artery. The recurrent laryngeal nerve may pass anterior or posterior to the 
artery, or between its branches . The lowest branch sends a twig to the 
inferior parathyroid gland and supplies the lower pole of the thyroid gland. 
The upper branch supplies the posterior surface of the gland, usually 
anastomosing with a descending branch of the superior thyroid artery. 
 The thyroid ima artery is unpaired and inconstant. It arises from the 
brachiocephalic artery, the right common carotid artery, or the aortic arch. It 
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occurs in about 10 percent of individuals, according to Montgomery(16). Its 
position anterior to the trachea makes it important in tracheostomy. 
Veins 
 Veins of the thyroid gland form a plexus of vessels lying in the 
substance and on the surface of the gland. The plexus is drained by three 
pairs of veins, the superior, middle, and inferior thyroid veins. 
 The superior thyroid vein accompanies the superior thyroid artery. 
Emerging from the superior pole of the thyroid, the vein passes superiorly 
and laterally across the omohyoid muscle and the common carotid artery to 
enter the internal jugular vein alone or with the common facial vein. The 
middle thyroid vein arises on the lateral surface of the gland at about two-
thirds of its anteroposterior extent. It crosses the common carotid artery to 
open into the internal jugular vein. The inferior thyroid vein is the largest 
and most variable of the thyroid veins. The right vein leaves the lower 
border of the thyroid gland, passes anterior to the brachiocephalic artery, and 
enters the right brachiocephalic vein. The left vein crosses the trachea to 
enter the left brachiocephalic vein. 
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Nerve supply 
 The left RLN arises from the vagus nerve where it crosses the aortic 
arch, loops around the ligamentum arteriosum, and ascends medially in the 
neck within the tracheoesophageal groove. The right RLN arises from the 
vagus at its crossing with the right subclavian artery. The nerve usually 
passes posterior to the artery before ascending in the neck, its course being 
more oblique than the left RLN.  
 The RLNs innervate all the intrinsic muscles of the larynx, except the 
cricothyroid muscles, which are innervated by the external laryngeal nerves. 
Injury to one RLN leads to paralysis of the ipsilateral vocal cord, which 
comes to lie in the paramedian or the abducted position. The paramedian 
position results in a normal, but weak voice, whereas the abducted position 
leads to a hoarse voice and an ineffective cough. Bilateral RLN injury may 
lead to airway obstruction, necessitating emergency tracheostomy, or loss of 
voice. 
 The superior laryngeal nerves also arise from the vagus nerves. After 
their origin at the base of the skull, these nerves travel along the internal 
carotid artery and divide into two branches at the level of the hyoid bone. 
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The internal branch of the superior laryngeal nerve is sensory to the 
supraglottic larynx. Injury to this nerve is rare in thyroid surgery, but its 
occurrence may result in aspiration. The external branch of the superior 
laryngeal nerve lies on the inferior pharyngeal constrictor muscle and 
descends alongside the superior thyroid vessels before innervating the 
cricothyroid muscle. 
 Sympathetic innervation of the thyroid gland is provided by fibers 
from the superior and middle cervical sympathetic ganglia. The fibers enter 
the gland with the blood vessels and are vasomotor in action. 
Parasympathetic fibers are derived from the vagus nerve and reach the gland 
via branches of the laryngeal nerves. 
 The thyroid gland contains two separate physiologic endocrine systems: 
one responsible for the production of the thyroid hormones thyroxine (T4) and 
triiodothyronine (T3) , and the other responsible for the production of the 
hormone calcitonin. The functional unit for thyroid hormone production is the 
thyroid follicle. This is composed of a single layer of cuboidal follicular cells 
surrounding a central space filled with colloid. The primary function of the 
thyroid follicle is to make and store thyroid hormones.Para-follicular C cells  
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FIG : LATERAL VIEW OF THYROID WITH BLOOD SUPPLY 
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are responsible for the production of calcitonin which acts in concert with 
parathyroid hormone (PTH) and vitamin D to regulate serum calcium levels..(3) 
 
PARATHYROIDS 
 In 1849, the curator of the London Zoological Gardens, Sir Richard 
Owen, provided the first accurate description of the normal parathyroid 
gland after autopsy examination of an Indian rhinoceros. However, human 
parathyroids were not grossly and microscopically described until 1879 by 
Ivar Sandström, a medical student in Uppsala, Sweden. He suggested that 
these glands be named the glandulae parathyroideae, although their function 
was not known. 
ANATOMY & EMBRYOLOGY 
 In humans, the superior parathyroid glands are derived from the fourth 
branchial pouch, which also gives rise to the thyroid gland. The third 
branchial pouches give rise to the inferior parathyroid glands and the 
thymus. 
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 The parathyroids remain closely associated with their respective 
branchial pouch derivatives. The position of normal superior parathyroid 
glands is more consistent, with 80% of these glands being found near the 
posterior aspect of the upper and middle thyroid lobes, at the level of the 
cricoid cartilage. Approximately 1% of normal upper glands may be found 
in the paraesophageal or retroesophageal space. Enlarged superior glands 
may descend in the tracheoesophageal groove and come to lie caudal to the 
inferior glands.(18) 
  The position of normal superior parathyroid glands is more consistent, 
with 80% of these glands being found near the posterior aspect of the upper 
and middle thyroid lobes, at the level of the cricoid cartilage. The position of 
the inferior glands, however, tends to be more variable due to their longer 
migratory path. Undescended inferior glands may be found near the skull 
base, angle of the mandible, or superior to the upper parathyroid glands 
along with an undescended thymus. The frequency of intrathyroidal glands 
is about 2%. Supernumerary glands were present in 13% of patients, most 
commonly in the thymus. Only 3% of patients had less than four glands.(4) 
 Both the superior and inferior parathyroids are usually supplied by the 
inferior thyroid artery: 86.1% on the right side, 76.8% on the left. In the  
23 
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absence of an inferior thyroid artery, both the superior and inferior parathyroid 
glands were supplied by the superior thyroid artery in the majority of cases.(5) 
 
HISTOLOGY 
 Histologically, parathyroid glands are composed of chief cells and 
oxyphil cells arranged in trabeculae, within a stroma composed primarily of 
adipose cells . The parathyroid glands of infants and children are composed 
mainly of chief cells, which produce parathyroid hormone (PTH). Acidophilic, 
mitochondria-rich oxyphil cells are derived from chief cells, can be seen around 
puberty, and increase in numbers in adulthood. A third group of cells, known as 
water-clear cells, also are derived from chief cells, are present in small 
numbers, and are rich in glycogen. Although most oxyphil and water-clear cells 
retain the ability to secrete PTH, their functional significance is not known.(4) 
 Perhaps all the parathyroid cells participate in the secretion of the 
parathyroid hormone, parathormone (PTH), and in the regulation of calcium 
and phosphate metabolism. To maintain normal calcium in the blood, a 
feedback system is formed between the circulating calcium and the secretion of 
PTH. Too much serum calcium inhibits production of PTH; too little stimulates 
secretion.(5) 
25 
 
 
 
FIG: NORMAL PARATHYROID HISTOLOGY SHOWING CHIEF 
CELLS INTERSPERSED WITH ADIPOSE CELLS. 
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PARATHYROID PHSIOLOGY & CALCIUM 
HOMEOSTASIS 
 Calcium exists in extracellular plasma in a free ionized state, as well 
as bound to other molecules. So-called normal plasma levels of total calcium 
vary between laboratories, but the range of (bound and unbound) calcium is 
usually between 8.5 and 10.2 mg/dL (2.2 and 2.5 mmol/L). The biologically 
inert bound fraction (55% of the total) binds to proteins. Changes in albumin 
alter total calcium levels significantly because the majority of protein-bound 
calcium associates with albumin (80%). A small percentage of calcium is 
associated with other proteins, such as β-globulins, or with nonprotein 
molecules, such as phosphate and citrate. Consequently, ionized calcium 
levels are measured when required. Forty-five percent of the total calcium is 
biologically active and exists in the ionized form, with a normal level of 4.5 
to 5.0 mg/dL. Ionized calcium levels are inversely affected by the pH of 
blood; a 1-unit rise in pH will decrease the ionized calcium level by 0.36 
mmol/L.[14] Accordingly, patients who are hypocalcemic and hyperventilate 
can enhance their hypocalcemic symptoms, including perioral paresthesia, 
tingling in the fingers and toes, muscle cramping, and seizures. 
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Levels of calcium are highly modulated through a delicate interplay between 
PTH, calcitonin, and vitamin D acting on target organs such as bone, kidney, 
and the gastrointestinal tract(6). 
 Chief cells in the parathyroid glands secrete PTH, an 84–amino acid 
protein, whenever serum calcium levels fall. PTH binds to its peripheral 
receptors and stimulates osteoclasts to increase bone resorption, the kidney 
to increase calcium resorption and renal production of 1,25-
dihydroxyvitamin D3 (1,25[OH]2D3), and the intestine to increase absorption 
of calcium and phosphate. Together, these processes raise the serum calcium 
level. The recently cloned calcium-sensing receptors (CaSRs) in the 
parathyroid glands detect changes in calcium levels, which results in a 
negative feedback loop that decreases PTH production.(7) 
Parathyroid Hormome(PTH) 
 The parathyroid cells rely on a G-protein coupled membrane receptor, 
designated the calcium-sensing receptor (CASR), to regulate PTH secretion 
by sensing extracellular calcium levels(19). PTH secretion also is stimulated 
by low levels of 1,25-dihydroxy vitamin D, catecholamines, and 
hypomagnesemia. The PTH gene is located on chromosome 11. PTH is 
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synthesized in the parathyroid gland as a precursor hormone preproPTH, 
which is cleaved first to pro-PTH and then to the final 84-amino-acid PTH. 
Secreted PTH has a half-life of 2 to 4 minutes. In the liver, PTH is 
metabolized into the active N-terminal component and the relatively inactive 
C-terminal fraction. The C-terminal component is excreted by the kidneys. 
 PTH functions to regulate calcium levels via its actions on three target 
organs, the bone, kidney, and gut. PTH increases the resorption of bone by 
stimulating osteoclasts and promotes the release of calcium and phosphate 
into the circulation. At the kidney, calcium is primarily absorbed in concert 
with sodium in the proximal convoluted tubule. PTH acts to limit calcium 
excretion at the distal convoluted tubule via an active transport mechanism. 
PTH also inhibits phosphate reabsorption (at the proximal convoluted 
tubule) and bicarbonate reabsorption. It also inhibits the Na+/H+ antiporter, 
which results in a mild metabolic acidosis in hyperparathyroid states. PTH 
and hypophosphatemia also enhance 1-hydroxylation of 25-hydroxyvitamin 
D, which is responsible for its indirect effect of increasing intestinal calcium 
absorption.(4) 
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Calcitonin 
           The Ca2+-lowering hormone has been named calcitonin. In 
nonmammalian vertebrates, the source of calcitonin is the ultimobranchial 
bodies, a pair of glands derived embryologically from the fifth branchial 
arches. In mammals, these bodies have for the most part become 
incorporated into the thyroid gland, where the ultimobranchial tissue is 
distributed around the follicles as the parafollicular cells, which are also 
known as the clear or C cells  
         Calcitonin is a 32–amino acid protein secreted by the parafollicular 
cells of the thyroid gland in response to high calcium levels. Measurement 
of circulating calcitonin by immunoassay indicates that it is not secreted 
until the plasma calcium level reaches approximately 9.5 mg/dL and that 
above this calcium level, plasma calcitonin is directly proportionate to 
plasma calcium. -Adrenergic agonists, dopamine, and estrogens also 
stimulate calcitonin secretion. Gastrin, CCK, glucagon, and secretin have all 
been reported to stimulate calcitonin secretion, with gastrin being the most 
potent stimulus. Human calcitonin has a half-life of less than 10 minutes. 
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Its actions oppose those of PTH. Calcitonin rapidly inhibits bone resorption, 
thereby leading to a transient decrease in serum calcium levels. Calcitonin 
plays a minimal, if any, role in the regulation of calcium levels in humans. 
However, it is very useful as a marker of MTC and in treating acute 
hypercalcemic crisis.(7) 
Vitamin D 
           The active transport of Ca2+ and PO43– from the intestine is increased 
by a metabolite of vitamin D. The term "vitamin D" is used to refer to a 
group of closely related sterols produced by the action of ultraviolet light on 
certain provitamins. 
            Vitamin D3, which is also called cholecalciferol, is produced in the 
skin of mammals from 7-dehydrocholesterol by the action of sunlight. The 
reaction involves the rapid formation of previtamin D3, which is then 
converted more slowly to vitamin D3. Vitamin D3 and its hydroxylated 
derivatives are transported in the plasma bound to a globulin vitamin D-
binding protein (DBP). Vitamin D3 is also ingested in the diet. 
 Vitamin D refers to vitamin D2 and vitamin D3 , both of which are 
produced by photolysis of naturally occurring sterol precursors. Vitamin D2 
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is available commercially in pharmaceutical preparations, whereas vitamin 
D3 is the most important physiologic compound and is produced from 7-
dehydrocholesterol, which is found in the skin. Vitamin D is metabolized in 
the liver to its primary circulating form, 25-hydroxyvitamin D. Further 
hydroxylation in the kidney results in 1,25-dihydroxy vitamin D, which is 
the most metabolically active form of vitamin D. Vitamin D stimulates the 
absorption of calcium and phosphate from the gut and the resorption of 
calcium from the bone. 
Summary 
The actions of the three principal hormones that regulate the plasma 
concentration of Ca2+ can now be summarized. PTH increases plasma Ca2+ 
by mobilizing this ion from bone. It increases Ca2+ reabsorption in the 
kidney, but this may be offset by the increase in filtered Ca2+. It also 
increases the formation of 1,25-dihydroxycholecalciferol. 1,25-
Dihydroxycholecalciferol increases Ca2+ absorption from the intestine and 
increases Ca2+reabsorption in the kidneys. Calcitonin inhibits bone 
resorption and increases the amount of Ca2+ in the urine. 
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CALCIUM BALANCE AND FLUXES IN A NORMAL HUMAN. 
 Solid arrows depict a direct effect, whereas dashed arrows depict an 
indirect effect. The thickness of the arrows is representative of the 
magnitude of the flux. ECF = extracellular fluid; PTH = parathyroid 
hormone; VIT. = vitamin 
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SIGNS & SYMPTOMS OF POST THYROIDECTOMY 
HYPOCALCEMIA 
 Hypoparathyroidism after thyroidectomy remains the most widely 
accepted cause of hypocalcaemia(20). Edis in 1979  reported that injury, 
devascularization or inadvertent removal of parathyroid tissue must be the 
first practical consideration in development of hypocalcaemia.(21) 
Ligation of the main trunk of inferior thyroid artery lateral in the neck during 
thyroidectomy gives good haemostasis and avoids injury to recurrent 
laryngeal nerves, but also it may interfere with the blood supply of 
parathyroids giving rise to hypoparathyroidism with subsequent 
hypocalcaemia.(20) 
 
SYMPTOMS 
 circumoral and fingertip numbness and tingling 
 Mental symptoms - anxiety, confusion, and depression 
 Muscle cramps 
 Convulsions 
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SIGNS 
 Chvostek sign- which is contraction of the facial muscles after tapping 
on the facial nerve anterior to the ear. Approximately 15% of normal 
individuals have a positive Chvostek sign, however.(7) 
 Trousseau's sign -carpopedal spasm which is elicited by occluding 
blood flow to the forearm  after inflation of a blood pressure cuff to 20 
mm Hg above the patient's systolic blood pressure for  for 2 to 3 
minutes. 
 Tetany- which is characterized by tonic-clonic seizures, carpopedal 
spasm, and laryngeal stridor & spasm and bronchospasm. 
 Prolongation of QT interval on ECG. 
 Contraction at the oral angle is seen in 10% - 25% of the population – 
good to test pre operatively(76) 
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        CHRONIC COMPLICATIONS OF HYPOCALCEMIA 
 
            Chronic complications are intracranial calcifications, particularly 
of the basal ganglia, various mental disturbances, such as irritability, 
depression, and even psychosis. Papilledema and other signs of increased 
intracranial pressure have been reported.  
 
            Chronic hypocalcemia may lead to cataract formation, 
abnormalities of the skin, nails and hair, candida infections and 
dermatology anomalies. Cardiac effects of hypocalcemia include 
prolongation of the QT interval and, rarely, congestive heart failure. 
Dental anomalies depend on the age at onset; in children hypocalcemia 
can cause enamel hypoplasia and failure of the adult teeth to erupt. 
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FIG:TROUSSEAU’S SIGN IN A PATIENT WITH HYPOCALCEMIC 
TETANY ( A.K.A  “ACCOUCHER'S HAND” ) 
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REVIEW OF LITERATURE 
 
Definition of Post-thyroidectomy hypocalcemia 
 
                  In review of literature there are different definitions of post 
thyroidectomy hypocalcemia mostly based on total serum calcium   
levels.(23-28) 
 “Postoperative hypocalcemia(hypoparathyroidism) was defined by 
postoperative Total serum Ca levels of less than 7.6mg/dl (normal range 
8.4-10.4 mg/dl) with or without clinical symptoms of hypocalcemia 
(neuromuscular irritability including paresthesia, muscle cramps, tetany, or 
seizures) or subnormal serum Ca levels(7.6-8.4 mg/dl) with neuromuscular 
symptoms during the first 4 postoperative days.”(22) 
 
 In our study we have taken a total serum calcium less than 8.5mg/dl 
arbitrarily as a cut off point for post-operative hypocalcemia. 
 
 Vocal cord paralysis, hemorrhage and hypocalcemia are the most 
common complications of thyroid and  parathyroid surgery Postsurgical 
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hypocalcemia is usually manifest within the first 24 to 48 hours following 
surgery. Generally, calcium values and parathyroid responsiveness improve 
within 1 week after surgery. (3) 
 
 If the pre-existing hyperparathyroidism resulted in excessive bone 
resorption, then a more severe, protracted form of postparathyroidectomy 
hypocalcemia referred to as "hungry bones" may ensue. “Hungry bone 
syndrome” is typically associated with more severe, symptomatic 
hypocalcemia and may require treatment for several weeks to months before 
biochemical parameters normalize. An elevated serum PTH level 
distinguishes hypocalcemia of hungry bones from other forms of post-
parathyroidectomy hypocalcemia.(3) 
 
ETIOLOGY 
 Etiology of postoperative hypocalcemia has not been definitively 
elucidated. However, several mechanisms have been proposed(29), 
1) Secondary to trauma which usually results from intentional or 
inadvertent extirpation of the parathyroid glands during 
thyroidectomy.(3) 
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2) From interruption of the blood supply to the glands with subsequent 
infarction 
3) Calciuretic effect of intraoperative fluid administration(transient per-
operative hemodilution) (29) 
4) Decreased parathormone secretion from atrophic glands.(30) 
5) “Hungry bone syndrome” related to remineralization of the 
skeleton.(31) 
6) Destruction of the parathyroid glands as a result of lymphadenectomy 
along the recurrent laryngeal nerve (RLN)(32) 
7) Hypoparathyroidism due to hematoma formation.(33) 
8) increased release of calcitonin as a result of  thyroid manipulation.(77) 
 
PREDICTORS OF POST-OP  HYPOCALCEMIA 
 Clinical and biochemically relevant predictive factors for the 
development of postoperative transient or permanent hypoparathyroidism, as 
well as how best to time its prediction, constitute a controversial topic in the 
literature.(22) 
 
40 
 
 Some studies describe decreasing sCa levels within the first 48 hours 
after surgery as a safe predictor of postoperative hypoparathyroidism.(34,35,36) 
According to the study by Reza et al the following are predictors for post-op  
hypocalcemia(22); 
 
(1.)Total serum Ca Levels 
 Predicting hypoparathyroidism on the first postoperative day by 
measuring total Serum calcium levels showed a sensitivity  of 18.6% with a 
specificity of 96.1%. On the second postoperative day, the sensitivity of 
Serum calcium level measurement rose to 62.8%, with a specificity of 
92.9%. The highest value of total Serum calcium measurement to predict 
hypoparathyroidism was documented on the third postoperative day 
with a sensitivity of 72.1%, a specificity of 92.9%, a PPV of 77.5%, and 
an NPV of 90.8%. 
(2.) Serum Calcium slope 
 Serum calcium levels were plotted as a function of time and the slope 
was defined as an increase or decrease in Serum calcium levels during 2 
consecutive measurements within 48 hours after operation (within 24 hours 
and on the second postoperative day).Serum Ca slope is calculated using the 
41 
 
following equation to evaluate its predictive value for postoperative 
normocalcemia or hypocalcemia; 
Slope=[(Calcium Level 2−Calcium Level 1)/Calcium Level 1]/(Time 
2−Time 1) 
 
 A positive Serum calcium slope, strongly predictive of a stable 
postoperative Serum calcium level, showed a sensitivity of 88.4%, a 
specificity of 35.4% for Postoperative hypocalcemia. 
 
(3.) Intact (i)PTH Level 
 The sensitivity of iPTH levels as the only predictive value for 
hypoparathyroidism on the first postoperative day (defining 
hypoparathyroidism with iPTH levels of 15 pg/mL or less) was 97.7%, with a 
specificity of 82.6%. The same sensitivity (97.7%) could be documented for 
the iPTH levels measured on the fourth postoperative day. 
 
(4.)  Combination of Serum calcium and Intact iPTH Levels 
             Using the combined interpretation, we observed the best result with 
iPTH values (definition of hypoparathyroidism, an iPTH level of <15 pg/mL) 
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measured on the first postoperative day and Serum calcium values (definition 
of hypoparathyroidism, Serum calcium level  of<7.6mg/dl) measured on the 
second postoperative day. 
 The most reliable predictor for determining transient or permanent 
hypoparathyroidism may be intraoperative  iPTH measurements.Finally 
Reza et al concluded that measuring iPTH levels 24 hours after total 
thyroidectomy in combination with Serum calcium levels on the second 
postoperative day allows the prediction of hypoparathyroidism with a high 
sensitivity, specificity, and positive predictive value.(22) 
 
(5.)Total free calcium(ionized Calcium level)(77) 
 Ionized calcium represents 50% of the total calcium and is the 
biologically important fraction that is highly regulated. The ionized calcium 
is calculated by assuming that the albumin concentration is 40 g/L. It is 
measured by total calcium concentration minus (measured albumin in g/L 
minus 40), multiplied by 0.02.(77) 
(6.) Other factors 
 According to a study by Yesim et al  preoperative serum 25-Hydroxy 
vitamin-D3 level less than 15 ng/mL, a postoperative serum PTH level less 
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than 10 pg/mL, and Age older than 50 years were significantly predictive 
factors for postoperative hypocalcemia.(78) 
 
REVIEW OF OTHER STUDIES 
            Although Lindblom et al found no overall significant difference 
between measurements of intact iPTH levels and measurements of Serum 
calcium concentrations on the first postoperative day for predicting long-term 
hypoparathyroidism, monitoring of intact iPTH levels could predict which 
patients may need intravenous calcium supplementation during the first 24 
hours postoperatively.(23) 
 
           There is considerable controversy in the literature regarding the 
utility of intact iPTHmeasurement for prediction of postoperative 
hypocalcemia in patients undergoing surgery for primary 
hyperparathyroidism. Warren et al.  concluded that intact iPTH levels > 15 
pg/ml after total thyroidectomy indicate a low risk of postoperative 
hypocalcemia.(37) 
             However  most studies recommending intraoperative monitoring of 
iPTH levels, levels that were less below the normal range at the end of or 
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immediately after the operation were highly correlative with postoperative 
hypoparathyroidism and seemed to allow for early prediction, with a 
sensitivity and specificity ranging from 71% to 100%.(23,41-43) 
 
 In addition, Higgins et al. concluded from their findings that 
intraoperative PTH monitoring is useful in predicting postoperative 
hypocalcemia following total thyroidectomy.(42) 
 
            In the study of Elaraj and co-researchers iPTH monitoring was able to 
predict postoperative hypocalcemia, but this correlation was significant only 
in multiglandular disease and not in patients with a single adenoma(38) 
 
 Lo et al.  conducted a study on the applicability of intraoperative 
hormone assay during thyroidectomy and concluded that iPTH monitoring 
during thyroidectomy enables the identification of patients at risk to develop 
postoperative hypocalcemia.(39) In the study by Quiros and colleagues ,72 
patients undergoing thyroid surgery underwent an Intra-operative Quick-
PTH monitoring, and the authors concluded that an Intra operative-Quick 
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PTH level < 10 pg/ml is a strong predictor of hypoparathyroidism after 
thyroid surgery(40). 
 
 Some authors ascribe a high predictive value to intraoperative or 
early perioperative measurement of intact parathyroid hormone levels 
(iPTH) challenging the common practice of assessing serum calcium (sCa) 
levels daily until an increase is observed.(23,41-44) Intra and postoperative 
intact parathyroid hormones has been embraced with enthusiasm by many 
surgeons as a means to detect patients with the highest risk of severe 
hypocalcemia, but its major limitation for wider clinical use is the cost 
factor. 
 
               However monitoring of iPTH levels during thyroidectomy may be 
easily organized in centers of endocrine (thyroid) surgery. However, most 
patients with thyroid problems are treated in smaller surgical units. 
Therefore, monitoring of intraoperative iPTH levels may be a logistical 
problem and increase the costs.(39,41,44) 
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 Others have suggested that Serum calcium concentrations should be 
measured only in selected patients(45) or during the initial 24-hour 
postoperative period.(34,35,36) 
 
 However decreased total Serum calcium levels measured on 
postoperative day 1 were observed in 97.6%. This phenomenon has 
frequently been debated and often partially explained by hemodilution after 
surgery .(46.47) 
 
 Certain authors recommend measurement of  free/ionized calcium 
levels in the assesment of  post thyroidectomy patients(Faiza A Qari et al(77)) 
because the fall in serum total protein level due to hemodilution associated 
with the stress of surgery causes a decrease in serum total calcium level 
unrelated to parathyroid function.(90.91) 
 
 Therefore, on the first 2 postoperative days, interpretation of intact 
iPTH levels in combination with serum Calcium levels seems an optimal 
strategy for predicting patients at risk of hypoparathyroidism and 
hypocalcemia.(27,41,44) 
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      MANAGEMENT OF POST-OP HYPOCALCEMIA 
 
 If the patient is asymptomatic with mild hypocalcemia (7.5 to 8.5 
mg/dL), oral therapy consisting of up to 1000 mg of elemental calcium every 
6 hours and 0.25 to 2.0 ug/day of calcitriol [I,25-(OH)z] vitamin D3 should 
be instituted. As with intravenous therapy, the oral doses can be titrated to 
keep the calcium in the low-normal range. Magnesium levels should be 
monitored and repleted because hypomagnesemia results in both impaired 
PTH secretion and PTH resistance. 
 
 In severe cases (calcium level < 7.5 mg/dL or severe symptoms), 
intravenous administration of calcium salts is required. A recommended 
approach includes using 10 ampules of calcium gluconate (90 mg of 
elemental calcium per lO-mL ampule) in I L of 5% dextrose with an initial 
infusion rate of 100 mL/hour. With frequent monitoring of serum calcium 
levels (usually every I to 2 hours), the infusion rate is titrated to keep the 
calcium level in the low-normal range. Once stabilized, the patient may be 
converted to a regimen of oral calcium and calcitriol as described earlier (4) 
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Regarding the duration of post-operative calcium supplementation,a review 
of literature gives varying time periods with a study by Kanis et al 
recommending a duration of supplementation of oral calcium with or 
without vitamin D3 for 3 to 6 months(80). 
 
 Another study by Faiza et al supports this duration of post-operative 
supplementation for 3-6 months.(77) 
 
 Unnecessary supplementation may cause hypercalcaemia and 
hypercalciuria which could results in renal failure.(81) 
 
 According to a study by Jong et al routine administration of a 
supplement containing oral calcium and vitamin D is effective in reducing 
the incidence and severity of hypocalcemia after total thyroidectomy. In this 
study, oral calcium (3 g) and vitamin D (1 g) were administered daily to 
patients for 2 weeks after total thyroidectomy. Given that serum calcium 
decreased after surgery and then recovered during the postoperative period 
of more than 1 month in this study, a treatment duration of 2 weeks is 
proposed. 
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 In a study by Moore et al  patients were given oral calcium on an 
empirical basis, an elderly patient supplemented with calcium 5 g/d for 2 
weeks became lethargic and hypercalcemic. Moore  has recommended that 
all patients having bilateral thyroid surgery, including total thyroidectomy, 
should have routine calcium supplementation prior to discharge from the 
hospital.(84) 
We therefore advocate routine oral calcium and vitamin D supplements in 
the prevention of postoperative hypocalcemia and for increasing the like-
lihood of a safe and early discharge from the hospital. This will ultimately 
lead to improved patient satisfaction and significant cost savings. 
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MEASURES TO PREVENT POST THROIDECTOMY 
HYPOCALCEMIA 
  When evaluating the patient prior to surgery, make sure to keep in 
mind risk factors for postop hypocalcemia,(76) 
 Hyperthyroidism 
 Large goiters 
 Preoperative low serum vitamin D (low sunlight, alcoholism etc) 
 Planned level 6 neck dissection, extensive cancer 
 
 Permanent hypocalcaemia can be avoided by keeping the plane of 
dissection near the capsule of thyroid gland to prevent, if possible, removal 
of parathyroid glands.(79) 
 
 Ligation of the inferior thyroid artery branches in the thyroid capsule 
should be favored over central ligation to preserve vascular supply to the 
parathyroids.(79) 
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Surgeons should look in the thyroid specimen for parathyroid glands that may 
have been removed and re-implant them. To avoid permanent 
hypoparathyroidism, autotransplantation of parathyroid glands is 
recommended.(48,49) 
 
 Zedenius et al25 found that, after routinely transplanting at least 1 
parathyroid gland into the sternocleidomastoid muscle, none of their 100 
consecutive patients undergoing total thyroidectomy developed permanent 
hypoparathyroidism. A similar experience was reported by Lo and Lam.(27,28) 
 
 However Parathyroid autotransplantation does not provide absolute 
protection against permanent hypoparathyroidism. (32,42) 
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                        MATERIALS AND METHODS 
 
 This study was carried out in 120 patients who underwent Near-
Total thyroidectomy and Total thyroidectomy in the department of 
general surgery,Government Rajaji Hospital,Madurai  during the period 
from 2010 January to December 2011. 
 This study which was undertaken was a prospective case series 
study and was started after getting due clearance from the Institute of  
Ethical committee(IEC),Government Rajaji Hospital.Madurai Medical 
College.Patients were included in this study after getting their informed 
written consent. 
 Inclusion criteria for patients in this study consist of -Patients of both 
sex and any age presenting with enlargement of both lobes of thyroid 
(includes both benign and malignant enlargement) proved by ultrasound 
(US) to be nodular & by laboratory investigations (Thyroid function test) to 
be euthyroid. 
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 Patients excluded were those with contra-indications for surgery and 
general anaesthesia and those who were not in a euthyroid state. 
 
 Data on patient’s demographics, operative aspects, postoperative 
recovery, complications  (post thyroidectomy hypocalemia) and results were 
collected. 
Patients in this study underwent an pre-operative assesment to confirm 
the diagnosis which included, 
(1)Full clinical History 
(2)Clinical examination 
(3) Fine Needle Aspiration Cytology 
(4) Thyroid function test (TFT) 
(5) Ultrasound Neck 
(6) Indirect laryngoscopy to assess vocal cord status. 
 All patients included in this study were to be  followed up for  
period of  6 months. 
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 Postoperative assessment will include the following: 
 Immediate post-op period: in the hospital looking for 
numbness  and other manifestations of hypocalcaemia along 
with serum  calcium* on the second post-op day. 
  after one month :serum calcium * 
 after six months : serum calcium levels* 
 
*
In our study a  free/ionised calcium assay was not done  due to non 
availability of this test in our institution and in private labs in madurai . 
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SURGICAL STRATEGY 
     In this study two types of surgery were used namely Near total 
thyroidectomy and Total thyroidectomy,however our aim is not to compare 
both techniques as the former surgery was used in majority of cases in our 
department. 
 
TOTAL THYROIDECTOMY 
 
 Total Thyroidectomy is complete removal of all thyroid tissue without 
leaving behind any remanant.In our Hospital (Govt.Rajaji Hospital) we 
currently use a total thyroidectomy only in cases suspicious of malignancy 
and proven cases of Carcinoma Thyroid.  
 
 Review of literature about this procedure is controversial as there are 
many divergent views about the indications of this procedure.In a recent 
editorial,Wheeler stated that “total thyroidectomy for benign thyroid disease 
is likely to become an accepted component of the endocrine surgeon’s  
armamentarium.” (50) 
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          Although there has been increasing acceptance for performing total-
thyroidectomy for well-differentiated thyroid carcinoma, surgeons still 
continue to debate whether the potential benefits outweigh the potential 
complications.  There are still some who argue that total thyroidectomy is an 
operation that is almost never justified.The use of total thyroidectomy for 
benign thyroid disease is there for even more controversial, although there are 
increasing numbers of reports recommending its use for bilateral benign 
multinodular goiter.(52-54) 
  
 The only real argument against total thyroidectomy is the potential for 
an increased risk of complications. However, there is good evidence to show 
that with increasing experience, the use of appropriate surgical technique, 
and, most important, the quality training of surgical residents, total 
thyroidectomy can be performed with minimal complications.(55,56) 
 
 In a study by Delbridge et al, the incidence of permanent recurrent 
laryngeal nerve palsy after total thyroidectomy was only 0.5% , the incidence 
of permanenthypoparathyroidism  and hypocalcemia was only 0.4%. 
Interestingly, this incidence was little different from the complication rates 
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recorded after subtotal thyroidectomy (0.2% for permanent recurrent laryngeal 
nerve palsy and 0.2% for permanent hypoparathyroidism). There is no 
question that hemostasis is more assured after total thyroidectomy when all 
vessels have been individually ligated than when dealing with an intact mass 
of residual vascularized thyroid tissue. parathyroid viability can be just as 
readily assured by a policy of aggressive parathyroid autotransplantation . 
However,temporary hypocalcemia remains a treatment problem after total 
thyroidectomy.(57) 
 
 Subtotal thyroidectomy was considered safe compared to total 
thyroidectomy (59), and it was thought that leaving behind some thyroid tissue 
would prevent thyroxine supplementaton With long follow-up of these cases, 
however, it was observed that nodular goiter often recurs after surgery, and the 
recurrence rate increases with time .(60) 
 
 In a study by Reeves et al Subtotal thyroidectomy may also lead to 
recurrent goiter in up to 23% of patients.(58)Another study by Rojdmark and 
Jarhult  noted a 42% recurrence rate after 30 years of follow-up in a group of 
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43 patients with multinodular goiter on whom subtotal thyroidectomy had 
been performed.(61) 
 
    Postoperative thyroxine suppression is advocated to prevent goiter 
recurrence. Failure of thyroxine suppression to prevent recurrence has been 
observed by many authors.(62,63,64) 
 
            There is another issue of underdiagnosed malignancy in casesof 
multinodular goiter and Graves’ disease. Subtotal thyroidectomyin this case 
represents inadequate surgery.(65,71) 
 
 Several studies have shown that total thyroidectomy can be performed 
with a morbidity rate comparable to that of less radical resections.(66,67,68)Reeve 
et al. considered it a preferred option, as reoperation for recurrent goiter is 
associated with increased morbidity.(58,69) Others studies have supported that 
view.(54,70) 
 
 Thus considering all the facts, total thyroidectomy represents the most 
logical and effective means of treating this disorder, provided the operation is 
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performed by experienced surgeons who have special interest in endocrine 
surgery.(69,71) 
 
Currently in our deparment in majority of cases a near-total thyroidectomy is 
done and total thyroidectomy reserved for cases suspicious and proven for 
malignancy and is usually combined with a modified radical neck dissection 
depending on the nodal status. 
 
NEAR TOTAL THYROIDECTOMY 
 
 Near-total thyroidectomy is defined as  performing a total lobectomy 
on the dominant side and a subtotal lobectomy on the contralateral side.(57)It 
consisted of total lobectomy in the lobe having the dominant nodule, with 
isthmectomy and sub-total lobectomy in the contralateral side, leaving a 
small quantity of about 2 g of thyroid tissue adjacent to the parathyroid 
glands and their blood supply.(72) 
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                     When the disorder affects both lobes, total or near-total 
thyroidectomy is mandatory, especially in younger persons, to obviate 
suppressive therapy and possible relapse.(72) 
 
           Subtotal thyroidectomy may be the best elective procedure in older 
patients to avoid total and permanent dependence on drugs.(73) 
 
 Ambrosi et al found that recurrence was inversely related to the extent 
of resection.(74) 
 
 The indications for total thyroidectomy for managing benign thyroid 
disorders are not well defined, in fact, they are evolving.(54,58,70) 
 
 An advantage of near-total thyroidectomy over subtotal thyroidectomy is 
that the thyroid remnant of about 2 g renders it accessible to 131I ablation if 
cancer is found in the specimen and obviates reoperation for completion 
thyroidectomy.(75) 
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 Permanent or temporary hypoparathyroidism is a well-known 
complication of total thyroidectomy. Excision of parathyroid glands and 
vascular insufficiency are the main causes of this complication. 
Identification of the parathyroid glands and meticulous surgical technique to 
preserve parathyroid circulation are essential during near-total 
thyroidectomy which were done by consultants or under their guidance in 
my study. 
 
So currently in our Department we prefer to use near- total thyroidectomy 
over total thyroidectomy for treatment of  benign enlargement of both lobes 
of thyroid.  
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FIG: A CASE OF CARCINOMA THYROID WITH BONE 
SECONDARIES (STERNUM) 
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FIG: NEAR TOTAL THYROIDECTOMY SPECCIMEN 
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OBSERVATION & RESULTS 
The findings of the study can be tabulated as follows. 
                                                 TABLE-I 
                       AGE DISTRIBUTION IN THE STUDY 
 
                                              TABLE-II 
                        SEX DISTRIBUTION IN THE STUDY 
 
SEX MNG COLLOID 
GOITRE 
TOXIC 
GOITRE 
CARCINOMA 
THYROID 
MALE 3 1 3 16 
FEMALE 66 7 13 11 
Age in 
years 
COLLOID 
GOITRE 
MNG TOXIC 
GOITRE 
CARCINOMA 
THYROID 
10-20 3 3 - - 
20-30 - 14 1 5 
30-40 2 20 6 7 
40-50 1 22 4 6 
>50 1 13 4 8 
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TABLE-IV 
DITRIBUTION OF HYPOCALCEMIA AMONG AGE GROUPS OF 
PATIENTS IN THE STUDY. 
 
   AGE(YEARS) 
                          HYPOCALCEMIA 
    TRANSIENT PERMANENT 
10-20 1 1 
20-30 3 - 
30-40 2 2 
40-50 5 1 
>50 15 5 
    TOTAL 26 9 
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TABLE-III 
DISTRIBUTION OF HYPOCALCEMIA IN THE STUDY AMONG 
THE DIADNOSES & PROCEDURES PERFORMED. 
                       HYPOCALCEMIA 
         TRANSIENT        PERMANENT 
DIAGNOSIS 
MULTINODULAR 
GOITRE 
8 1 
COLLOID GOITRE 1 - 
TOXIC GOITRE 2 2 
CARCINOMA 
THYROID 
15 6 
PROCEDURE 
NEAR-TOTAL 
THYROIDECTOMY 
11 2 
TOTAL 
THYROIDECTOMY 
6 2 
TOTALTHYROIDECTOMY
WITH MRND 
9 5 
TOTAL 26 9 
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TABLE-V 
DISTRIBUTION OF SIGNS AND SYMPTOMS OF 9 
SYMPTOMATIC PATIENTS. 
SIGNS&SYMPTOMS PATIENTS
Chvostek 3
Paraesthesia&Numbness 5
Trousseau 3
Myalgias 5
Facial spasms 4
Carpal spasms 2
Pedal spasms 1
 
Total patients with hypocalcemia, n=26 
Symptomatic patients=9  (34%) 
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DISCUSSION 
 
 In our study which is a prospective type  120 patients were included 
over a period of  2 years from January 2010 to December 2011.Regarding 
the sex distribution in this study, as per Table-II there were 23 males 
(19.2%) and 117 females(81.8%),thus we can infer that thyroid disorders are 
overwhelmingly more common in the fairer sex.But malignancy of thyroid 
gland was more common in male gender(60% of cases), probably male 
gender being in a greater risk for malignancy as per the AGES/AMES 
Criteria for thyroid malignancies.(7) 
 But the benign disorders of thyroid were more common among 
females in age group of 20-50 yrs(60%) as per Table-I. Malignant disorders 
of thyroid were more common after 50 yrs  of age. 
 The incidence of hypocalcemia in our study was 26 cases out of 
120 operated (21.6%).Out of the 26 cases that developed hypocalcemia in 
our study 9 patients(34.6%) went in for permanent hypocalcemia or 
hypoparathyroidism which is defined as hypocalcemia persisting after 6 
months of surgery, so  we can put it in another way by saying that 35% of 
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patients with transient hypocalcemia went in for permanent 
hypoparathyroidism requiring lifelong calcium and/or vitamin D3 
supplementation. 
 So the incidence of permanent hypocalcemia in our study is  7.5%. 
 Regarding the distribution of hypocalcemia in our study (Table-III) 
,there is a greater risk of developing  hypocalcemia after malignant disorders 
of thyroid (58% of hypocalcemic pts). Also the rate of conversion to 
permanent hypocalcemia is  40% in malignancy of thyroid(6 out of 15 
patients went in for permanent hypocalcemia after surgery),while the 
incidence of permanent hypocalcemia is 3% in benign thyroid disorders,out 
of which 2 cases  developed permanent hypocalcemia ,which was due to a 
Near-total thyroidectomy being performed for Toxic goiter and may be as a 
result of “Hungry bone syndrome” causing the post-operative hypocalcemia 
where serum calcium is sequestered in bone after the underlying pathology 
is removed..This can be explained by figure-II which shows the extent of 
surgery performed and the occurrence of hypocalcemia which is more after 
more extensive procedures like Total thyroidectomy with/without modified 
radical neck dissection.Though the incidence of  hypocalcemia after Near 
Total Thyroidectomy is 11.5%(11 out of 96 operated cases),this was only a 
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transient post-operative hypocalcemia and only two of these patients went in 
for a permanent hypocalcemic/hypoparathyroid state which was after 
surgery for toxic goiter for the reasons mentioned before. 
 In addition the incidence of hypocalcemia following malignant 
thyroid disorders is more than 50% (62.5%; 15 out of 24 cases.)  and out of 
which 6 patients (25%) went in for permanent hypocalcemia. 
 Finally as we can see from figure-III out of 26 cases of hypocalcemia 
recorded in our study only 9 patients(35%) were symptomatic. Among these 
9 symptomatic patients we infer from Table-V that the most common 
symptom occurring in hypocalcemic patients is  paraesthesias, numbness 
and myalgias(5 cases) followed by  facial spasms(4 cases) and chvosteks and 
trousseau’s sign (3 cases each). 
 The reported incidence of post-thyroidectomy hypocalcemia varies 
from 1.6% to 50%  when we review literature(92,93), estimates of the 
incidence of post-thyroidectomy hypoparathyroidism vary widely, ranging 
from 6.9% to 46% for transient and 0.4% to 33% for permanent 
hypoparathyroidism.(86) 
                      Chow et al reported 16% permanent hypocalcaemia after total 
thyroidectomy, an incidence, which reached to 30% when patients had 
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thyroid cancers. In 310 patients with total thyroidectomy in the Chaudhary 
series, 17 patients (5.48%) had hypocalcaemia, 12 patients transient, and 5 
had permanent hypocalcaemia.(84,85) 
 
         A multicenter prospective trial by Thomusch et al  of 5846 patients 
undergoing total thyroidectomy revealed an incidence of transient 
hypoparathyroidism of 7.3% and permanent hypoparathyroidism of 1.5%.(86) 
When we compare the statistics of these authors with ours (transient 
hypocalcemia-21.6%; permanent hypocalcemia-7.5%), our rates are on the   
slightly higher side which probably could be due to more extensive surgery 
performed in our series for more number of malignant disorders of thyroid in 
onr study. 
 
               As regard the underlying thyroid pathology, higher incidence of hypo-
calcaemia with malignant (25%) and Toxic goitre (11.4%) than that in simple 
nodular goiter (3.6%) the high incidence of hypocalcaemia in thyro-toxicosis was 
noted also by Wingert et al reported an incidence of 59% for hypocalcaemia after 
thyroidectomy for thyrotoxicosis versus 3% incidence  after thyroidectomy for 
simple non toxic goiter.(94). Many theories developed to explain this high 
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incidence of hypocalcaemia after thyroidectomy for thyrotoxicosis, Golding and 
Krane noted that in thyrotoxicosis there is increased bone catabolism and it has 
been demonstrated that the degree of thyrotoxic osteodystrophy increases 
proportionally with the severity of thyrotoxicosis. Michie et al postulated that the 
presence of osteodystrophy that excisted after surgery that was called “Hungery 
bone syndrome” is a possible explanation.(95) 
 
               In the Ganecalves series of total thyroidectomy for thyroid cancer, 
transient hypocalcaemia was reported in 25.5% of cases and permanent 
hypocalcaemia in 5.1%; when radical neck dissection was added to total 
thyroidectomies, these rates increased.(87),on comparison with our series our 
values are higher (transient hypocalcemia-62.5%; permanent hypocalcemia-
25%%) again probably due to more  frequency of concomitant radical neck 
dissections performed along with a total thyroidectomy in our series. 
 
 According to a study by Vayesberg et al , skill and experience of 
surgeons in performing total thyroidectomies were evaluated and 
hypocalcaemia was observed in 6.3% of the patients ,the incidence being 
inversely proportional to skill and experience of surgeon.(88) 
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 However a survey by the American College of Surgeons reported an 
incidence of hypoparathyroidism following total thyroidectomy as 8%.(89)In 
our study the reported incidence following total thyroidectomy is 28% again 
due to the more extensive procedures performed (neck dissections combined 
with total thyroidectomy) and due to the absence of utilisation auto-
transplantation of parathyroids in our study. 
 
 
          Finally permanent hypoparathyroidism is slightly more frequent in cases 
of thyroidectomy for hyperthyroidism, thyroid carcinoma, or after previous 
neck surgery—three conditions in which parathyroid preservation may be 
jeopardized by technical difficulties. Indeed, the number of parathyroid glands 
preserved during thyroidectomy appeared to be the major determinant of the 
outcome. 
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CONCLUSION 
 
 Postoperative hypocalcemia is the most common and sometimes the 
most severe  and potentially debilitating complication observed after Near 
total thyroidectomy and Total thyroidectomy. 
 
 The incidence of hypocalcemia(transient) in our study is 21.6%  and 
permanent hypocalcemia requiring lifelong calcium and/or vitamin D3 
supplementation is 7.5%. 
 
 So proper planning and meticulous surgical technique with special 
emphasis in localization and preserving the vascularity of atleast one para-
thyroid gland will go a long way in reducing this complication. 
 
 We should employ newer techniques like auto-transplantation of 
parathyroids, use of Ultra sonic shears and enhanced bipolar diathermy 
which may help in bringing down the incidence of post-operative 
hypocalcemia. 
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               We can avoid Transient/Permanent hypocalcemia or 
hypoparathyroidism by searching for parathyroid glands in the post-
operative specimen, if detected immediate auto-transplantation of 
parathyroids will reduce the incidence of transient/permanent hypocalcemia 
following thyroidectomies. 
 
               Proper post-operative monitoring and early detection by 
performing a serum calcium assay and even an intact-iPTH assay( if 
available and affordable ) is mandatory to prevent post-operative distress to 
patients. 
 
 Adequate and timely calcium and /or vitamin D3 supplementation is 
advised in patients at risk for developing post-operative hypocalcemia and 
for treatment of all symptomatic patients. 
 
 Finally a proper follow-up schedule is mandatory in all patients 
undergoing Near-Total Thyroidectomy and Total Thyroidectomy. 
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                                              PROFORMA   
NAME OF PATIENT     : 
AGE/SEX                        : 
IP NUMBER                   : 
ADDRESS & CONTACT NO  : 
DATE OF ADMISSION  : 
DATE OF SURGERY      : 
DATE OF DISCHARGE  : 
DIAGNOSIS                   : 
SURGERY DONE         : 
INVESTIGATIONS 
TFT                               : T3=       , T4=        , TSH= 
FNAC                           : 
ULTRASOUND NECK   : 
SERUM CALCIUM 
 IMMEDIATE POST OP PERIOD : 
 AFTER ONE MONTH                  : 
 AFTER SIX MONTHS                        : 
ANY SIGNS & SYMPTOMS OF HYP0CALCEMIA 
 IMMEDIATE POST OP PERIOD : 
 AFTER ONE MONTH                 : 
 AFTER SIX MONTHS                   : 
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MASTER CHART 
 
SL.NO:  IP NO:  AGE  SEX     DIAGNOSIS    PROCEDURE                HYPOCALCEMIA 
TRANSIENT  PERMANENT 
1.  095573  50  F  MNG  NTT  N  N 
2.  092940  40  F  CA THYROID  TT  N  N 
3.  097556  35  F  COLLOID GOITRE 
 
NTT  N  N 
4.  103316  25  F  CA THYROID  TT WITH RT.MRND  P  N 
5.  107092  26  F  TOXIC MNG  NTT  P  N 
6.  107080  43  F  MNG  NTT  N  N 
7.  004383  18  F  MNG  NTT  N  N 
8.  004388  20  M  CA THYROID  TT WITH LT. FND  N  N 
9.  013760  28  F  MNG  NTT  N  N 
10.  017324  50  F  CA THYROID  TT  N  N 
11.  018241  50  F  TOXIC MNG  NTT  N  N 
12.  033321  51  F  MNG  NTT  N  N 
13.  035611  36  F  MNG  NTT  N  N 
14.  036658  22  F  MNG  NTT  N  N 
15.  O40546  38  M  MNG  NTT  N  N 
16.  044425  44  F  MNG   NTT  N  N 
17.  052339  50  F  MNG  NTT  N  N 
18.  054169  35  M  CA THYROID  TT WITH RT.MRND  P  P 
19.  050362  43  M  TOXIC MNG  NTT  N  N 
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20.  060211  45  F  MNG  NTT  N  N 
21.  065787  14  F  MNG  NTT  N  N 
22.  069712  40  F  MNG  NTT  P  N 
23.  063928  40  F  TOXIC MNG  NTT  N  N 
24.  050383  27  F  CA THYROID   TT  P  N 
25.  072238  62  M  TOXIC MNG  NTT  N  N 
26.  073902  42  F  TOXIC MNG  NTT  N  N 
27.  075537  59  F  CA THYROID  TT WITH RT.MRND  N  N 
28.  084974  48  M  CA THYROID   TT  N  N 
29.  085066  38  F  TOXIC MNG  NTT  N  N 
30.  088048  70  F  MNG  NTT  N  N 
31.  092620  37  F  MNG  NTT  N  N 
32.  000480  42  M  CA THYROID  TT WITH BIL.MRND  P  P 
33.  004290  44  F  MNG  NTT  N  N 
34.  005167  23  F  MNG  NTT  N  N 
35.  008366  55  F  TOXIC MNG  NTT  P  P 
36.  009964  52  F  MNG  NTT  N  N 
37.  014799  48  F  CA THYROID  TT  N  N 
38.  014783  30  F  MNG  NTT  N  N 
39.  017975  48  F  MNG  NTT  N  N 
40.  013183  31  F  TOXIC MNG  NTT  N  N 
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SL.NO:  IP NO:  AGE  SEX     DIAGNOSIS    PROCEDURE                HYPOCALCEMIA 
TRANSIENT  PERMANENT 
41.  024044  26  F  MNG  NTT  N  N 
42.  025637  39  F  MNG  NTT  N  N 
43.  027371  15  F  MNG  NTT  N  N 
44.  025712  50  F  TOXIC MNG  NTT  P  P 
45  021070  36  M  CA THYROID  TT  P  N 
46.  025724  32  F  CA THYROID  TT WITH RT. MRND  P  P 
47.  033428  57  F  CA THYROID   TT  N  N 
48.  032275  41  F  MNG  NTT  N  N 
49.  032404  48  F  MNG  NTT  P  N 
50.  314472  45  F  TOXIC MNG  NTT  N  N 
51.  030575  37  F  TOXIC MNG  NTT  N  N 
52. 
 
033952  50  F  MNG  NTT  N  N 
53.  040454  46  F  MNG  NTT  N  N 
54.  038830  40  F  MNG  NTT  N  N 
55.  043836  40  F  MNG  NTT  N  N 
56.  042401  42  M  CA THYROID  TT WITH RT.MRND  P  N 
57.  045488  55  F  MNG  NTT  N  N 
58.  045591  29  F  MNG  NTT  N  N 
59.  040143  38  F  COLLOID GOTRE  TT  N  N 
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60.  041345  42  F  MNG  NTT  N  N 
61.  046123  17  F  COLLOID GOITER  NTT  N  N 
 
62.  056321  25  F  MNG  NTT  N  N 
63.  056361  35  F  MNG  NTT  N  N 
64  057234  38  F  MNG  NTT  N  N 
65  057452  29  F  MNG  NTT  N  N 
66  058312  37  F  MNG  NTT  N  N 
67  058567  52  F  MNG  NTT  N  N 
68  059321  60  F  MNG  NTT  P  N 
 
69  059679  47  F  MNG  NTT  N  N 
70.  067452  53  F  MNG  NTT  N  N 
71.  006834  38  F  MNG  NTT  N  N 
72  078124  39  M  MNG  NTT  N  N 
73.  079235  45  F  MNG  NTT  N  N 
74.  079658  19  F  COLLOID GOITER  NTT  N  N 
75.  082349  29  F  MNG  NTT  P  N 
 
76.  085675  45  M  MNG  NTT  N  N 
77  086789  42  F  MNG  NTT  N  N 
78.  087821  52  F  MNG  NTT  N  N 
79.  093216  38  F  MNG  NTT  P  N 
80.  096591  50  F  MNG  NTT  N  N 
98 
 
 
SL.NO:  IP NO:  AGE  SEX     DIAGNOSIS    PROCEDURE                HYPOCALCEMIA 
TRANSIENT  PERMANENT 
81.  057279  60  F  COLLOID GOTER  TT  P  N 
82.  045959  33  F  MNG  NTT  N  N 
83.  045952  42  F  CA THYROID  TT  N  N 
84.  074151  65  M  CA THYROID  TT WITH RT. MRND  N  N 
85.  078044  37  F  CA THYROID  TT WITH BIL. MRND  P  P 
86.  078105  50  F  CA THYROID  TT WITH BIL. MRND  P  P 
87.  034329  32  F  TOXIC MNG  TT  P  N 
88.  009122  47  F  MNG  NTT  N  N 
89.  096481  35  F  MNG  NTT  N  N 
90  100573  24  F  MNG  NTT  N  N 
91  017418  28   F  MNG  TT  N  N 
92.  033108  55  M  CA THYROID  TT  P  P 
93.  043319  33  F  MNG  NTT  N  N 
94  044275  32  F  MNG  NTT  N  N 
95  046272  31  F  MNG  NTT  N  N 
96  070251  25  F  MNG  NTT  N  N 
97  078931  45  M  CA THYROID   TT WITH BIL. MRND  N  N 
98  083481  35  F  MNG  NTT  N  N 
99  086451  29  F  MNG  NTT  N  N 
99 
 
100.  098321  46  F  MNG  NTT  N  N 
101.  083457  65  M  CA THYROID  TT WITH BIL. MRND  P  N 
102.  079780  33  F  TOXIC MNG  TT  N  N 
103.  083379  45    M  MNG  NTT  N  N 
104  021070  36  M  CA THYROID  TT  N  N 
105.  030579  65  M  CA THYROID  TT WITH LT. MRND  P  N 
106.  015911  35  M  TOXIC MNG  TT  N  N 
107.  054169  35  M  CA THYROID  TT  P   N 
108  056789  47  F  MNG  NTT  N  N 
109  057345  36  F  MNG  NTT  N  N 
110.  065007  60  M  CA THYROID  TT  P   N 
111.  015949  37  M  CA THYROID  TT WITH RT.MRND  P  N 
112.  083379  45  F  MNG  NTT  N  N 
113  085679  36  F  MNG  NTT  N  N 
114  086123  18  F  COLLOID GOITER  NTT  N  N 
115  087345  29  F  MNG  NTT  N  N 
116.  088122  43  F  MNG  NTT  P  N 
177.  041790  65  M  CA THYROID  TT  N  N 
118.  095671  45  F  COLLOID GOITER  NTT  P  N 
119.  109872  38  F  MNG  NTT  N  N 
120.  039479  22  F  MNG  NTT  N  N 
100 
 
KEY TO MASTER CHART 
 
DIAGNOSIS 
MNG     =  MULTI NODULAR GOITER 
 
PROCEDURE 
NTT      =   NEAR TOTAL THYROIDECTOMY 
TT         =  TOTAL THYROIDECTOMY 
MRND  =  MODIFIED RADICAL NECK DISSECTION 
FND      =   FUNCTIONAL NECK DISSECTION 
 
HYPOCALCEMIA 
N =  NOT PRESENT 
P =  PRESENT 
 
 
